In the ovarian carcinoma model, mice (n = 4 for the research group and n = 7 for the GMP group) were implanted with 3 × 105 IGROV-1 tumor cells, and seven days later were infused iv with 4.5 × 106 CD19 or CD44v6 CAR T cells. This evidence concerns the gene CD19 and ovarian carcinoma.